Brock signs agreement with Lorus Therapeutics Inc. to develop anticancer drugs
The fight against cancer has been bumped up a notch following Brock University’s agreement with Lorus Therapeutics Inc. to develop novel anticancer drugs.
The fight against cancer has been bumped up a notch following Brock University’s agreement with Lorus Therapeutics Inc. to develop novel anticancer drugs.
Synthetic Pathways and Brock University are hosting the 15th Symposium on the Latest Trends in Organic Synthesis.